1 Introduction 7
1.1 Industry Definition and Research Scope 7
1.1.1 Industry Definition 7
1.1.2 Research Scope 8
1.2 Research Methodology 11
1.2.1 Overview of Market Research Methodology 11
1.2.2 Market Assumption 12
1.2.3 Secondary Data 12
1.2.4 Primary Data 12
1.2.5 Data Filtration and Model Design 13
1.2.6 Market Size/Share Estimation 14
1.2.7 Research Limitations 15
1.3 Executive Summary 16
2 Market Overview and Dynamics 19
2.1 Market Size and Forecast 19
2.1.1 Impact of COVID-19 on World Economy 20
2.1.2 Impact of COVID-19 on the Market 22
2.2 Major Growth Drivers 24
2.3 Market Restraints and Challenges 30
2.4 Emerging Opportunities and Market Trends 33
2.5 Porters Fiver Forces Analysis 37
3 Segmentation of Asia Pacific Market by Offering 41
3.1 Market Overview by Offering 41
3.2 Services 43
3.3 Test Kits & Consumables 44
4 Segmentation of Asia Pacific Market by Application 45
4.1 Market Overview by Application 45
4.2 Non-Hodgkins Lymphoma (NHL) 47
4.2.1 DLBCL 49
4.2.2 Marginal Zone Lymphoma 50
4.2.3 Follicular Lymphoma 51
4.2.4 Peripheral T-cell Lymphoma 52
4.2.5 Mantle Cell Lymphoma 53
4.2.6 Other NHLs 54
4.3 Multiple Myeloma (MM) 55
4.4 Acute Lymphoblastic Leukemia (ALL) 56
4.5 Chronic Lymphoblastic Leukemia (CLL) 57
4.6 Acute Myeloid Leukemia (AML) 58
4.7 Chronic Myeloid Leukemia (CML) 59
4.8 Hodgkins Lymphoma (HL) 60
4.9 Solid Tumor 61
4.10 Other Applications 62
5 Segmentation of Asia Pacific Market by Technology 63
5.1 Market Overview by Technology 63
5.2 Flow Cytometry 65
5.3 Polymerase Chain Reaction (PCR) 66
5.4 Next-Generation Sequencing (NGS) 67
5.5 Other Technologies 68
6 Segmentation of Asia Pacific Market by End User 69
6.1 Market Overview by End User 69
6.2 Hospitals and Clinics 71
6.3 Research Institutions 72
6.4 Diagnostic Laboratories 73
6.5 Other End Users 74
7 Asia-Pacific Market 2021-2031 by Country 75
7.1 Overview of Asia-Pacific Market 75
7.2 Japan 78
7.3 China 81
7.4 Australia 83
7.5 India 86
7.6 South Korea 88
7.7 Rest of APAC Region 90
8 Competitive Landscape 92
8.1 Overview of Key Vendors 92
8.2 New Product Launch, Partnership, Investment, and M&A 96
8.3 Company Profiles 97
Adaptive Biotechnologies Corporation 97
ArcherDX, Inc. (Invitae Corporation) 99
Arup Laboratories 100
Asuragen Inc. 101
Bio-Rad Laboratories, Inc. 102
Cergentis B.V. 103
Guardant Health 104
ICON plc 105
Inivata Ltd. 106
Invivoscribe, Inc. 107
Laboratory Corporation of America Holdings 108
Mission Bio, Inc. 109
Natera, Inc. 110
NeoGenomics Laboratories, Inc. 111
Opko Health, Inc. 112
Quest Diagnostics Incorporated 113
Sysmex Corporation 114
RELATED REPORTS 115